How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Etiometry Release: Company Reaches 10 Million Hours Of Patient Monitoring Data To Enhance ICU Patient Care January 24, 2017 Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug August 24, 2017 North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017
Etiometry Release: Company Reaches 10 Million Hours Of Patient Monitoring Data To Enhance ICU Patient Care January 24, 2017
North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017
